AI is no longer a future consideration for pharmaceutical supply chain operators, according to Nitin Jayakrishnan, co-founder and CEO of Freehand.
Cencora’s Matt Sample and Gregg Gorniak explain why AI should recommend, not decide, and why pharma needs an agent strategy ...
Anthony "TJ" Rizzo, chief commercial officer at Cold Chain Technologies, says the biggest risk his customers face as ...
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and ...
FDA finalized guidance setting out how drug sponsors should label, describe and submit content from software used alongside ...
In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior ...
AI agents are moving into healthcare faster than most organizations can supervise them. In this conversation, Amy Brown, CEO of Authenticx, argues that every AI agent will eventually fail—and that the ...
AI is starting to resolve shipment exceptions and flag demand shifts, but early deployments show that connected data and ...
At LogiPharma USA 2026, BMS’s Kevin Cook explains why CMO partnerships must move beyond transactions toward shared goals and ...
Avantor’s Mary Blenn outlines five considerations for biopharma supply chain localization, from customer demand visibility to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results